A name is a label, not a conclusion
A compound may be known by a formal chemical name, a short research code, an abbreviation, or a name based on the natural molecule it resembles. More than one name can refer to the same compound, and similar-looking names can refer to meaningfully different molecules.
A name does not establish identity, quality, approval status, or evidence. Those are separate questions that must be checked against the exact compound and source.
Separate the molecule from what it interacts with
A receptor is a molecule inside or on the surface of a cell that binds a specific substance and produces a cellular effect. A compound that binds to a receptor is sometimes called a ligand.
An agonist binds to and activates a receptor response. An antagonist binds in a way that blocks or reduces activation. Partial agonists and other signaling patterns add more nuance, but the central distinction is whether and how receptor activity changes.
Separate a mechanism from an outcome
A mechanism is the proposed biological sequence connecting an intervention to an effect. It explains why an outcome might be plausible.
An outcome is what a study actually measures—for example, a laboratory value, symptom score, event, or change over time. A mechanism can guide a research question, but it cannot substitute for measuring the outcome itself.
Key terms
- Analog
- A compound structurally similar to a reference compound. Its chemical or biological properties may differ.
- Receptor
- A molecule in or on a cell that binds a substance and produces a specific cellular effect.
- Agonist
- A substance that binds to a receptor and activates a response.
- Antagonist
- A substance that blocks or reduces receptor activation rather than producing the same response.
- Mechanism
- A biological explanation for the steps through which an effect may occur.
- Outcome
- A prespecified measurement used to evaluate what happened in a study.
- Preclinical
- Laboratory or animal research conducted before—or apart from—testing the question directly in people.
- Clinical
- Research involving people.
Relay diagram
Four layers that should not be collapsed
What this can—and cannot—tell us
What it can tell us
- Which molecule, target, or biological action a source is discussing.
- Whether a claim describes a proposed mechanism or a measured outcome.
- Which exact term should be verified before comparing sources.
What it cannot establish alone
- That similarly named compounds are interchangeable.
- That receptor activation produces a meaningful outcome in people.
- That a nickname or product label verifies identity, quality, or approval.
Go deeperOptional · about 1 minute
Why an analog may behave differently
IUPAC defines an analog by structural similarity to a reference compound and explicitly notes that chemical or biological properties may differ. A structural change can alter receptor affinity, signaling, stability, or distribution.
The phrase analog of therefore establishes a relationship—not equivalence.
Why outcomes need to be named precisely
ClinicalTrials.gov defines an outcome measure as a prespecified measurement used to determine the effect of an experimental variable on study participants. The exact outcome and time frame matter.
A change in a biomarker, a change in symptoms, and a change in a major health event are all outcomes, but they do not answer the same question.
The takeaway
If you only remember one thing from this guide:
Before interpreting a claim, ask which layer it describes: the molecule, its target, a proposed mechanism, or a measured outcome.
Sources and support4 sources
- NCI Dictionary of Cancer Terms: receptor National Cancer Institute
Defines a receptor as a molecule in or on a cell that binds a specific substance and causes a cellular effect.
- NCI Dictionary of Cancer Terms: agonist National Cancer Institute
Defines an agonist by receptor binding and activation of the corresponding action.
Defines structural similarity and notes that analogs may have different chemical or biological properties.
- Results Data Element Definitions ClinicalTrials.gov
Defines an outcome measure as a prespecified measurement used to evaluate an experimental variable’s effect.